Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. Julie K. Heimbach, M.D., is a transplant surgeon and the surgical director of Transplantation at the Transplant Mayo Clinic in Rochester, MN. Her primary clinical care interests include adult and pediatric liver transplantation and living-donor surgery, improving outcomes for liver transplant recipients with obesity-related liver disease, advancing techniques for living-donor hepatectomy and striving to ensure long-term donor safety following donor surgery, improving outcomes for liver transplant recipients with hilar cholangiocarcinoma treated with neoadjuvant chemoradiotherapy followed by liver transplantation, and coordination of our multidisciplinary approach to care of the patient with end-stage liver disease before and after their transplant. Additionally, Dr. Heimbach leads practice convergence effort across the three Mayo Clinic liver transplant programs in Arizona, Florida and Minnesota to ensure all locations are providing the optimal care for patients. Dr. Heimbach is also very active in the development of national organ allocation policy. She is currently on the Board of the Organ Procurement and Transplantation Network (OPTN) and is also serving as the vice-chair of the OPTN Liver-Intestine Committee.